Search Results 181-190 of 17335 for globulin
These patients are at high risk for progression of kidney disease, which can result in end-stage renal failure. Participation eligibility. Participant ...
Patients undergoing a T-cell depleted allogeneic transplantation (using ex vivo CD34 selection, or with serotherapy {antithymocyte globulin or alemtuzumab}).
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Patients who received, or are planned to receive, abatacept or belatacept, within 3 months of screening, or who received equine anti-thymocyte globulin ...
A high hemoglobin (Hb or Hgb) count is a blood test result. It means that the level of a key protein in red blood cells called hemoglobin is higher than is ...
The purpose of this study is to evaluate the new QFT-Plus assay compared to the QFT-Gold assay and the tuberculin skin test results (as available) for the ...
The purpose of this study is to evaluate the safety and effectiveness of the BCL2 inhibitor BGB-11417 in participants with relapsed/refractory Waldenström's ...
... GLOBULIN,192 301000584,HC SIROLIMUS ASSAY,218 301000589,HC SODIUM ASSAY OTHER SOURCES,58 301000590,HC SODIUM ASSAY URINE,43 301000591,HC SODIUM SERUM/PLASMA ...
... globulin, or required dialysis within 12 weeks before Screening. Received a live vaccination within 4 weeks before Screening or planned between Screening ...
Planned use of anti-thymocyte globulin (ATG) or alemtuzumab in conditioning regimen. Planned post-transplant therapy, including use of tyrosine-kinase ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!